LFMD LifeMD, Inc.

NASDAQ
$2.97

LifeMD, Inc. (LFMD) is expected to report earnings on November 10, 2026, after the market close. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -7.8% since its last earnings release on August 5, 2026.

LifeMD Beat Consensus Estimates, Lowers Guidance
Wednesday, August 5, 2026 · 4:11 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 10
Tuesday · 4:10 PM ET
Earnings Whisper
-
vs ($0.14)
Rev est $48.93M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.27

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About LifeMD, Inc.

LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings.

Sector

Healthcare

Industry

Healthcare Info Services

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.